MTOR and hepatocellular carcinoma: Besides, miR-199a could not only increase sensitivity to cisplatin via enhancement of autophagy by targeting autophagy-associated gene 7(ATG7) [51], but also increase doxorubicin sensitivity of HCC cells by regulating mammalian target of rapamycin (mTOR) and c-Met [52] (Table, 1).